Resistant Candidiasis

AIDS Research and Human Retroviruses

Volumn 10, Issue 8, 1994, Pages 925-929

  Powderly, William G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; CANDIDIASIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUCONAZOLE; HUMAN; RECURRENCE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027938432     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.1994.10.925     Document Type: Article

References (40)

1. Powderly WG.: Fungal infections on patients with AIDS. In: Antifungal Agents, Vol. 1: Fluconazole. Powderly WG and Van't Wout J (Eds.). Marius Press, Carnforth, Lancashire, England, 1992, pp. 70–81.
2. Coleman DC., Bennett DE., Sullivan DJ., Gallagher PJ., Henman MC., Shanley DC., and Russell RJ.: Oral Candida in HIV infection and AIDS: New perspectives/new approaches. Crit Rev Microbiol 1993; 19: 61–82.
3. Itin PH., Lautenschlager S., Flückiger R., and Rufli T.: Oral manifestations in HIV-infected patients: Diagnosis and management. J Am Acad Dermatol 1993; 29: 749–760.
4. Wheat LJ.: Diagnosis and management of fungal infections in AIDS. Curr Opin Infect Dis 1993; 6: 617–627.
5. McCarthy GM., Mackie ID., Koval J., Sandu HS., and Daley TD.: Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991; 30: 332–336.
6. Feigal DW., Katz MH., Greenspan D., etal: The prevalence of oral lesions in HIV-infected homosexual and bisexual men: Three San Francisco epidemiological cohorts. AIDS 1991; 5: 519–515.
7. Bruatto M., Vidotto V., Marinuzzi F., Raiteri R., and Sinicco A.: Candida albicans biotypes in human immunodeficiency virus type 1 infected patients with oral candidiasis before and after antifungal therapy. J Clin Microbiol 1991; 29: 726–730.
8. Pons V., Greenspan D., Debruin M., and the Multicenter Study Group: Therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. J AIDS 1993; 6: 1311–1316.
9. Smith DE., Midgley J., Allan M., Connolly GM., and Gazzard BG. Itraconazole versus ketoconazole in the treatment of oral and esophageal candidosis in patients infected with HIV. AIDS 1991; 5: 1367–1371.
10. Bonacini M., Young T., and Laine L.: The causes of esophageal symptoms in human immunodeficiency virus infection: A prospective study of 110 patients. Arch Intern Med 1991; 151: 1567–1572.
11. Selik RM., Starcher ET., and Curran JW.: Opportunistic diseases reported in AIDS patients: Frequencies, associations, and trends. AIDS 1987; 1: 175–182.
12. Sha B., Benson C., Pottage J. Jr, Urbanski P., Daugherty S., and Kessler H.: HIV infection in women: A six year longitudinal observational study. Abstract PO-B01-0891. In: Proceedings of the IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 283.
13. Duerr A., Sierra M., Clarke L., Landesman S., Ehrlich I., Minkoff H., etal: Vaginal candidiasis among HIV-infected women. Abstract, PO-B01-0880. In: Proceedings of the IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 282.
14. Glatt AE.: Therapy for oropharyngeal candidiasis in HIV-infected patients. J AIDS 1993; 6: 1317–1318.
15. Como JA. and Dismukes WE.: Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263–272.
16. Cotton D. and Weinberg D. Survey results: Treatment decisions in HIV care. AIDS Clin Care 1992; 4: 85–91.
17. Just-Nubling G., Gentschew FG., Meissner K., etal: Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1991; 10: 917–921.
18. Stevens DA., Greene SI., and Lang OS.: Thrush can be prevented in patients with acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100 mg oral fluconazole daily. Arch Intern Med 1991; 151: 2458–2464.
19. Marrott DJE., Jones PD., Hoy JF., Speed BR., and Harkness JL.: Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. Med J Aust 1993; 158: 312–316.
20. Nightingale SD., Cal SX., Peterson DM., etal: Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS 1992; 6: 191–194.
21. Powderly WG., Robinson K., and Keath EJ.: Molecular epidemiology of recurrent oral candidiasis in HIV-positive patients: Evidence for two patterns of recurrence. J Infect Dis 1993; 168: 463–466.
22. Cameron ML., Schell WA., Bruch S., Bartlett JA., Waskin HA., and Perfect JR.: Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993; 37: 2449–2453.
23. Pfaller MA., Rhine-Chalberg J., Redding SW., etal: Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994; 32: 59–64.
24. Millon L., Manteaux A., Reboux G., etal: Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994; 32: 1115–1118.
25. Powderly WG.: Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 1992; 6: 604–605.
26. Wingard JR., Merz WG., Rinaldi MG., etal: Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
27. Galgiani JN.: Susceptibility testing of fungi: Current status of the standardization process. Antimicrob Agents Chemother 1993; 37: 2517–2521.
28. Porro GB. and Parente F.: Opportunistic infections of the oesophagus in AIDS patients: Clinical and therapeutic problems. J Intern Med 1993; 233: 107–110.
29. Fan-Harvard P., Capano D., Smith SM., Mangia A., and Eng RHK.: Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991; 35: 2302–2305.
30. Fox R., Neal K., Leen C., Ellis M., and Mandai B.: Fluconazole resistant Candida in AIDS. J Infect 1991; 22: 201–203.
31. Willocks L., Leen D., Brettle R., Urquhart D., Russell T., and Milne L.: Fluconazole resistance in AIDS patients. J Antimicrob Chemother 1991; 20: 917–921.
32. Baily GG., Perry FM., Denning DW., and Mandai BK.: Fluconazole resistant candidiasis in an HIV cohort. Abstract PO-B09-1375. In: Proceedings ofthe IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 364.
33. Berman S. and Ho M.: Highly resistant esophageal candidiasis in patient with AIDS. Abstract PO-B09-1405. In: Proceedings of the IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 369.
34. Boken DJ., Swindells S., and Rinaldi MG.: Fluconazole-resistant Candida albicans. Clin Infect Dis 1993; 17: 1018–1021.
35. Newman S., Fisher A., Rinaldi M., Stein M., Vigilante K., and Flanigan TP.: Clinically significant Candida mucositis resistant to high dose fluconazole in patients with AIDS. Abstract PO-B09-1372. In: Proceedings of the IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 364.
36. Troillet N., Durussel C., Bille J., Glauser MP., and Chave JP.: Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993; 12: 911–915.
37. Heinic GS., Stevens DA., Greenspan D., etal: Fluconazole resistant Candida in AIDS patients. Report of two cases. Oral Surg Oral Med Oral Pathol 1993; 76: 711–715.
38. Koletar SL., Weed HG., and Ramundo MB.: Thrush unresponsive to treatment with fluconazole in HIV-infected patients. Abstract 35. In: First National Conference on Human Retroviruses and Related Infections. American Society for Microbiology, Washington, D.C., 1993, p. 61.
39. Coker RJ., Tomlinson DR., Parkin J., Harris JR., and Pinching AJ.: Interaction between fluconazole and rifampicin. Br Med J 1990: 301: 818.
40. Cartledge JD., Midgley J., Youle M., Fisher M., and Gazzard BG.: Use of cyclodextrin solution formulation of itraconazole (ITRSOL) to treat candidiasis unresponsive to other azole preparations in patients with AIDS. Abstract WS-B12-2. In: Proceedings of the IXth International Conference on AIDS, Berlin, Germany, 1993, Vol. I, International AIDS Society, p. 55.